RDF of MGI data
pubmed
K. Shide, et.al., Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F., Leukemia, 2008, 22
http://rdf.ncbi.nlm.nih.gov/pubmed/18033315
K. Shide, et.al., Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F., Leukemia, 2008, 22(pubmed)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
K. Shide, et.al., Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F., Leukemia, 2008, 22
pubmed
allele
http://purl.org/net/cito/citesAsAuthority
Tg(H2-K<b>-Jak2*V617F)2Shmd
http://metadb.riken.jp/db/mgi_rdf/MGI:5444028
Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>
http://metadb.riken.jp/db/mgi_rdf/MGI:5444031
表現型アノテーション
http://purl.org/net/cito/citesAsAuthority
enlarged spleen_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000691IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
decreased hematocrit_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0000208IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
abnormal spleen morphology_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0000689IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased spleen red pulp amount_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0008476IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
decreased spleen white pulp amount_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0008479IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased erythroblast number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0011178IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
abnormal spleen morphology_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000689IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
myeloid hyperplasia_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0010373IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
myeloid hyperplasia_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0010373IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased megakaryocyte cell number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0008254IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
abnormal neutrophil morphology_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0005065IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
decreased erythroblast number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0011179IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
enhanced megakaryocyte emperipolesis_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0020399IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased compact bone thickness_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0004148IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
thrombocytosis_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0005505IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased number of Howell-Jolly bodies_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0010178IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
abnormal megakaryocyte morphology_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0002417IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased spleen red pulp amount_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0008476IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased granulocyte number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000322IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
abnormal definitive hematopoiesis_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0002123IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
polychromatophilia_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0005097IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
decreased hematocrit_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000208IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
decreased erythrocyte cell number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0002875IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
enhanced megakaryocyte emperipolesis_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0020399IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased spleen weight_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0004952IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
myelofibrosis_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0011747IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
polycythemia_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0002872IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased bone marrow cell number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000321IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased neutrophil cell number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0000219IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased leukocyte cell number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0000218IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
decreased erythroid progenitor cell number_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0008973IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
giant platelets_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0030025IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
decreased erythroid progenitor cell number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0008973IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
enlarged spleen_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0000691IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
spleen fibrosis_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0011746IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased spleen weight_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0004952IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
decreased hemoglobin content_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0002874IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
anemia_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0001577IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
abnormal megakaryocyte morphology_Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>/Dcc<+>
http://metadb.riken.jp/0002417IC57BL6DBA2DccTgH2KbJak2V617F1ShmdDccDccDccTgH2KbJak2V617F1Shmd
increased megakaryocyte cell number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0008254IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
thrombocytosis_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0005505IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
abnormal definitive hematopoiesis_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0002123IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
increased leukocyte cell number_Tg(H2-K<b>-Jak2*V617F)2Shmd/0
http://metadb.riken.jp/0000218IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd
class
http://purl.org/net/cito/citesAsAuthority
Tg(H2-K<b>-Jak2*V617F)2Shmd
http://metadb.riken.jp/db/mgi_rdf/MGI:5444028
Dcc<Tg(H2-K<b>-Jak2*V617F)1Shmd>
http://metadb.riken.jp/db/mgi_rdf/MGI:5444031
お問い合わせ
システムのお問い合わせ
画像
足跡